UK Breast Cancer Consultants

Dr Niladri Ghosal is a Consultant Clinical Oncologist based at The North Wales Cancer Treatment Centre, Glan Clywd.

Dr Ghosal has had experience of working in other cancer centres which include The Christie in Manchester, Royal Preston Hospital and Saint James's University Hospital Leeds.  Dr Ghosal treats his patients in the best possible evidence based way and is guided by experience.  He is always available for open and detailed communications with his patients.

Dr Ghosal trained in Clinical Oncology at The Christie Hospital in Manchester and joined as a Consultant in North Wales Cancer Treatment Centre in 2010. 

He is the lead in Acute Oncology services in Wrexham Maelor Hospital, and his main interests are in advanced radiotherapy techniques such as Intensity Modulated Radiotherapy (IMRT), Image Guided Radiotherapy (IGRT) and Stereotactic Ablative Radiotherapy (SABR) as well as combining chemotherapy with radiotherapy.

Dr Ghosal is also the lead for implementation of SABR in North Wales Cancer Treatment Centre. He offers all treatments for Breast, Lung and Brain Cancers.

Dr Carys Thomas is a Consultant Clinical Oncologist based at the Kent Oncology Centre.

Dr Thomas trained at Jesus College, Cambridge and University College London, qualifying in 1998. Thereafter she gained general medical experience in London, and commenced her specialist oncology registrar posts training at University College Hospital, Mount Vernon Cancer Centre, Royal Surrey Hospital and Guys and St Thomas’ Hospital. She obtained Fellowship to the Royal College of Radiologists in 2005.  She was awarded a clinical research fellowship in radiation oncology at the British Columbia Cancer Agency in Vancouver, Canada, where she specialised in prostate brachytherapy and researching in breast cancer.  In 2007 Dr Thomas became a Consultant in East Kent and her main clinical interests are in the management of breast, urological (prostate, bladder and kidney) and gynaecological cancers. 

Dr Thomas has an interest in radiotherapy, chemotherapy and hormone therapies. She has extensive experience of using highly technical radiotherapy, including Intensity Modulated Radiotherapy (IMRT) and Image Guided Radiotherapy (IGRT). 

Nationally she sits on the executive committee of the British Uro-oncology Group providing educational guidance on urological cancers. She is keen on education and has been the Royal College Tutor for oncology as well as Associate Professor to St George’s Medical School, Granada.

Dr Carys Thomas is also a member of The Royal College of Radiologist, The Royal College of Physicians, The European Society for Therapeutic Radiotherapy and Oncology, British Medical Association and the American Brachytherapy Society.

Dr Anne Armstrong is a Consultant Medical Oncologist at The Christie in Manchester.

After qualifying from Bristol University in 1995 Dr Armstrong underwent specialist training at The Christie.  She was awarded a PhD from The University of Manchester in 2002 investigating the use of vaccines against cancer.

Anne was appointed as a consultant medical oncologist in 2007 at The Christie and subsequently as an Honorary Senior Lecturer at the University of Manchester.

Dr Armstrong has an active roll in clinical research and is a member of the NCRN Breast Clinical Studies Group, and the NICE Familial Breast Cancer Guideline Development Group. She is the principal investigator for a number of clinical trials and also sits on the National Cancer Research Network breast clinical studies group.

Professor Andrew Baildam is a Consultant Breast Surgeon working in Manchester and London.

In 1993 Professor Baildam was appointed as Consultant Oncoplastic Breast Surgeon to the Christie Hospital regional cancer centre and to the University Hospital of South Manchester. He has been at the core of developments in breast cancer surgery and reconstruction over the last years and has immense experience in the management of breast disease.

Professor Baildam was appointed as Professor of Breast and Oncoplastic Surgery in 2011 at St Bartholomew’s Hospital, University of London. The majority of Professor Baildam’s career had previously been in Manchester. He trained in general surgery and surgical oncology and diverted into plastic and reconstructive breast surgery training at a time when cross-specialty training was radical. His MD thesis research was jointly between the Christie and the Middlesex, London, on the molecular biology of breast cancer. 

Professor Baildam has published over 180 peer-reviewed papers, chapters and articles. He jointly innovated the UK national breast oncoplastic surgery training fellowships set up in 2002. He is past President of BASO (British Association of Surgical Oncology), The Association for Cancer Surgery (2010-2012), and an interspecialty member of BAPRAS (British Association of Plastic Reconstructive and Aesthetic Surgeons). He chaired the BASO-BAPRAS Interface Group for three years.

Dr Abbas Chittalia is a Consultant Clinical Oncologist at The Christie NHS Foundation Trust.

After completing an undergraduate and postgraduate training in India Dr Chittalia migrated to the UK in 1999. He joined The Christie in 2001 and undertook his oncology training there from 2001 to 2006, where he was appointed as a Consultant Clinical Oncologist. Dr Chittalia specialises in the treatment of breast cancer. Dr Chittalia also provides palliative radiotherapy services for cancer related pain.

His aim is to ensure all patients receive the highest standard of care in a most efficient and timely manner. He is a member of the breast cancer disease orientated group at The Christie and attends regular national and international meetings to stay informed on all developments in cancer care.

Mr Lester Barr is a Senior Consultant Breast Surgeon based in Manchester.

Lester has been a Consultant Surgeon working at the Christie Hospital and the University Hospital of South Manchester since 1996. His principle areas of expertise are the diagnosis and management of breast cancer and breast reconstruction surgery.

Mr Barr's research interest is breast cancer prevention, and he is Chairman of Genesis Breast Cancer Prevention at the Genesis Prevention Centre in Manchester. He runs a diagnostic ‘one-stop’ breast clinic at Spire Manchester on Wednesdays and Thursdays, and a ‘Second Opinion’ clinic at the Christie Clinic on a Tuesday.

Dr Greg Wilson is a Consultant Medical Oncologist based at The Christie NHS Foundation Trust in Manchester.

Dr Wilson has interests in breast cancer, colorectal cancer and targeted liver therapies such as SIRT and ChemoSaturation.

He sees private patients at The Christie Clinic in Manchester, The Alexandra Hospital in Cheadle, The London Oncology Clinic and The Harley Street Clinic in London.

He graduated in Medicine from the University of Glasgow in 1988 and after working as a junior doctor in the UK, spent four years in Australia, working firstly in General Medicine and then latterly at advanced trainee level in Medical and Radiation Oncology in Sydney. After returning to the United Kingdom, he completed Specialist Training in Medical Oncology at St James’s University Hospital in Leeds.  He was appointed to the post of Consultant Medical Oncologist at The Christie Hospital, Manchester in 2002.

He is a senior member of the Breast and Colorectal Cancer Groups at The Christie and is closely involved in the Breast and Colorectal Cancer Research Programmes and is principal investigator in national and international trials at The Christie.  

He has a particular interest in the treatment of complex secondary breast and bowel cancer.  He set up, and is Lead Clinician for the Selective Internal Radiation Therapy (SIRT) service for secondary liver tumours and the targeted liver tumour programme at The Christie, the biggest contracted NHS/Private SIRT service in the UK.

He is an educational supervisor within the junior doctor programme and a lecturer in the undergraduate and postgraduate teaching programmes through the University of Manchester and The Christie NHS Trust.

He is active in social media on twitter (@uk_oncologist) and is on the European Society of Medical Oncology Social Media committee and believes in personalized care for individual patients and their needs.  More information can be found on his website drgregwilson.co.uk.